Cargando…

Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis

BACKGROUND: Acute Epstein-Barr virus (EBV) infection could lead to atherogenic lipid profile changes in adults; while there is no evidence about the children with Infectious mononucleosis (IM). The aim of this study was to evaluate the lipid profile of the children in acute phase of mononucleosis an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayyahfar, Shirin, Lavasani, Amin, Nateghian, Alireza, Karimi, Abdollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382049/
https://www.ncbi.nlm.nih.gov/pubmed/28332346
http://dx.doi.org/10.3947/ic.2017.49.1.44
_version_ 1782520037369708544
author Sayyahfar, Shirin
Lavasani, Amin
Nateghian, Alireza
Karimi, Abdollah
author_facet Sayyahfar, Shirin
Lavasani, Amin
Nateghian, Alireza
Karimi, Abdollah
author_sort Sayyahfar, Shirin
collection PubMed
description BACKGROUND: Acute Epstein-Barr virus (EBV) infection could lead to atherogenic lipid profile changes in adults; while there is no evidence about the children with Infectious mononucleosis (IM). The aim of this study was to evaluate the lipid profile of the children in acute phase of mononucleosis and two months after the recovery. MATERIALS AND METHODS: From 2010 through 2012, 36 children with IM aged 1-10 years were enrolled in a prospective cross-sectional study. Fasting serum total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), and triglyceride level were measured during acute phase of the disease and after 2 months of the recovery. RESULTS: From 36 patients enrolled, 25 (69.4%) cases were male and the mean age of the patients was 4.1 ± 2.0 years. The mean of the total cholesterol level in the acute phase and 2 months after the recovery were149.5 ± 35.3 mg/dL and 145.7±30.6, respectively (P = 0.38). However, the serum level of HDL cholesterol in patients after 2 months of recovery was significantly increased (37.9 ± 9.3 mg/dL vs. 28.5 ± 10.6 mg/dL, P <0.001). The mean value of serum LDL cholesterol was significantly reduced, two months after recovery (81.4 ± 19.5 mg/dL, vs. 92.6 ± 28.8 mg/dL, P = 0.009). Furthermore, the serum triglyceride level was significantly reduced after the recovery (108.7 ± 36.9 mg/dL) compared with the acute phase (163.8 ± 114.3 mg/dL) (P = 0.004). CONCLUSION: EBV infection in children could change lipid profile which is partially restored 2 months after the recovery.
format Online
Article
Text
id pubmed-5382049
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
record_format MEDLINE/PubMed
spelling pubmed-53820492017-04-06 Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis Sayyahfar, Shirin Lavasani, Amin Nateghian, Alireza Karimi, Abdollah Infect Chemother Original Article BACKGROUND: Acute Epstein-Barr virus (EBV) infection could lead to atherogenic lipid profile changes in adults; while there is no evidence about the children with Infectious mononucleosis (IM). The aim of this study was to evaluate the lipid profile of the children in acute phase of mononucleosis and two months after the recovery. MATERIALS AND METHODS: From 2010 through 2012, 36 children with IM aged 1-10 years were enrolled in a prospective cross-sectional study. Fasting serum total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), and triglyceride level were measured during acute phase of the disease and after 2 months of the recovery. RESULTS: From 36 patients enrolled, 25 (69.4%) cases were male and the mean age of the patients was 4.1 ± 2.0 years. The mean of the total cholesterol level in the acute phase and 2 months after the recovery were149.5 ± 35.3 mg/dL and 145.7±30.6, respectively (P = 0.38). However, the serum level of HDL cholesterol in patients after 2 months of recovery was significantly increased (37.9 ± 9.3 mg/dL vs. 28.5 ± 10.6 mg/dL, P <0.001). The mean value of serum LDL cholesterol was significantly reduced, two months after recovery (81.4 ± 19.5 mg/dL, vs. 92.6 ± 28.8 mg/dL, P = 0.009). Furthermore, the serum triglyceride level was significantly reduced after the recovery (108.7 ± 36.9 mg/dL) compared with the acute phase (163.8 ± 114.3 mg/dL) (P = 0.004). CONCLUSION: EBV infection in children could change lipid profile which is partially restored 2 months after the recovery. The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2017-03 2017-03-13 /pmc/articles/PMC5382049/ /pubmed/28332346 http://dx.doi.org/10.3947/ic.2017.49.1.44 Text en Copyright © 2017 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Sayyahfar, Shirin
Lavasani, Amin
Nateghian, Alireza
Karimi, Abdollah
Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis
title Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis
title_full Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis
title_fullStr Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis
title_full_unstemmed Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis
title_short Evaluation of Lipid Profile Changes in Pediatric Patients with Acute Mononucleosis
title_sort evaluation of lipid profile changes in pediatric patients with acute mononucleosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382049/
https://www.ncbi.nlm.nih.gov/pubmed/28332346
http://dx.doi.org/10.3947/ic.2017.49.1.44
work_keys_str_mv AT sayyahfarshirin evaluationoflipidprofilechangesinpediatricpatientswithacutemononucleosis
AT lavasaniamin evaluationoflipidprofilechangesinpediatricpatientswithacutemononucleosis
AT nateghianalireza evaluationoflipidprofilechangesinpediatricpatientswithacutemononucleosis
AT karimiabdollah evaluationoflipidprofilechangesinpediatricpatientswithacutemononucleosis